Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
XTL Biopharmaceuticals Announces Extraordinary General Meeting of Shareholders

XTL Biopharmaceuticals Announces Extraordinary General Meeting of Shareholders

BitgetBitget2026/11/20 21:09
  • XTL Biopharmaceuticals will hold an extraordinary shareholder meeting on December 28, 2026, at its attorneys’ offices in Tel Aviv, Israel.
  • Shareholders will consider a private placement of up to US$ 1 million involving investors including director Alexander Rabinovich.
  • A proposed name change to Psyga, or a similar name, is also on the agenda.
  • Yaron Kopel’s proposed CEO engagement terms include options to purchase up to 550,000 American Depositary Shares, each representing 400 ordinary shares.
  • Other proposals cover Guy Rosen’s three-year external-director appointment, compensation and conditional grant of options to purchase 1,000,000 ordinary shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XTL Biopharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-122698), on November 20, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!